The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

Signos’s glucose-tracking system uses AI and real-time data to guide healthier habits—no prescription required.

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous ...

The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, ...

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s ...

Signos, a purpose-driven metabolic health platform committed to transforming lives through personalized, real-time insights, today announced the launch of Signos Glucose Monitoring System, the first ...

Palo Alto, California-based Signos integrated the Dexcom Stelo OTC continuous glucose monitor (CGM) with an AI-powered ...

The FDA on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, establishing a new option for Americans to manage their weight. The Signos ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Men's Health Weight loss drugs like Ozempic can raise low testosterone — what that means for men By Tracy Swartz Published July 14, 2025, 3:00 p.m. ET ...

The Food and Drug Administration approved the first-ever glucose monitoring system specifically for weight management from ...

The FDA approved the first over-the-counter glucose monitoring system designed to help with weight management. Developed by health technology company Signos, the system combines the Stelo by Dexcom ...